Print Friendly, PDF & Email

Building facilities of the future: This collaboration reimagines what’s possible in biopharmaceutical manufacturing

GE Healthcare announces digital collaboration with Rockwell Automation to help drug manufacturers improve efficiencies, get to market faster, and deliver personalized medicines.

As automation, Artificial Intelligence (AI) and big data become today’s hottest buzzwords, biopharmaceutical manufacturing is entering its next evolutionary stage: biopharma 4.0. In this new era, next-generation technologies are providing more data with advanced analytics and modeling technologies that can be used for advanced process control and efficiency improvements.

That’s why GE Healthcare and Rockwell Automation Inc. – the world’s largest company dedicated to industrial automation and information – are combining their automation, IT and single-use solution expertise to build bioprocessing operations for the digital age.

This collaboration will help biopharmaceutical companies create flexible and scalable facilities of the future, focused on rapid response to market demands, streamlined production technologies and adaptable manufacturing environments. Combining GE Healthcare’s expertise in bioprocess manufacturing with Rockwell Automation’s expertise in automation will help drug manufacturers improve efficiencies, get to market faster, and deliver personalized medicines with innovative solutions.

Automation improves operational efficiency with reduced production risk and streamlines workflows, resulting in faster times to market. This collaboration leverages the combined expertise in single-use bioprocessing with deep automation and IT knowledge to turn data insights into productive outcomes.

Together, GE Healthcare and Rockwell Automation can help companies:

Gain greater efficiency with FlexFactory™ single-use equipment integrated with Figurate™ bioprocess automation that improves reproducibility, repeatability and compliance.

•  Gain greater efficiency with FlexFactory™ single-use equipment integrated with Figurate™ bioprocess automation that improves reproducibility, repeatability and compliance.
•  Digitize batch files and processes to reduce review times by weeks and even achieve real-time reviews.
•  Deliver instructions to workers with augmented reality to improve batch execution, operations, equipment setup and training.

GE Healthcare also joined the Rockwell Automation PartnerNetwork program as an OEM partner to help drive a best-in-class distributed control system offering. This program offers global manufacturers access to a collaborative network of companies mutually focused on developing, implementing and supporting best-in-breed solutions to achieve plant-wide optimization, improve machine performance and meet sustainability objectives.

 

“Our collaboration with GE Healthcare will help make bioprocessing operations more agile. The facility of the future reimagines what’s possible in production of biopharmaceuticals. It uses connectivity, information, and modular equipment to create smaller-scale, more efficient operations,” says Fran Wlodarczyk, senior vice president, Architecture and Software, Rockwell Automation. “As GE Healthcare becomes a member of our PartnerNetwork program, our joint work will help GE Healthcare bring the Connected Enterprise to life, so they can meet demands for more targeted drugs and get products to market faster.”

Collaborations like this are a critical step in transforming biopharmaceutical manufacturing with solutions that will optimize efficiencies and meet the needs of the biopharma 4.0 era.

“As GE Healthcare and the healthcare ecosystem move toward precision health, flexible and scalable solutions are critical for companies to efficiently manufacture smaller batches of tailored medicines,” says Kevin Seaver, executive general manager, Bioprocess Automation and Digital, GE Healthcare. “Our collaboration with Rockwell Automation is an integral part of our strategy to confirm we deliver innovative solutions that meet the needs of the biopharma 4.0 era.”